Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Insulin dosage optimization based on prediction of postprandial glucose excursions under uncertain parameters and food intake

  • García Jaramillo, Maira Alejandra
  • Calm, R.
  • Tarin, C.
  • Vehi, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
Considering the difficulty in selecting correct insulin doses and the problem of hyper- and hypoglycemia episodes in type 1 diabetes, dosage-aid systems are very useful for these patients. A model-based approach to this problem must unavoidably consider uncertainty sources such as large intra-patient variability and food intake. In the present study, postprandial glucose is predicted considering this uncertain information using modal interval analysis. This approach calculates a safer prediction of possible hyper- and hypoglycemia episodes induced by insulin therapy for an individual patient's parameters and integrates this information into a dosage-aid system. Predictions of a patient's postprandial glucose at 5-h intervals are used to predict the risk for a given therapy. Then the insulin dose and injection-to-meal time with the lowest risk are calculated. The method has been validated for three different scenarios corresponding to preprandial glucose values of 100, 180 and 250 mg/dl., This work was partially supported by the Spanish Ministry of Science and Innovation and the European Union through grant DPI-2007-66728 and by the Autonomous Government of Catalonia through SGR00523.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Real-Time Continuous Glucose Monitoring in an Intensive Care Unit: Better Accuracy in Patients with Septic Shock

  • Lorencio, Carol
  • Leal, Yenny
  • Bonet Alonso, Alfonso
  • Palerm, César C.
  • Tache, Abdo
  • Sirvent, Josep Maria
  • Vehi, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Objective: This study assessed the accuracy of real-time continuous glucose monitoring system (RTCGMS) devices in an intensive care unit (ICU) to determine whether the septic status of the patient has any in¿uence on the accuracy of the RTCGMS. Subjects and Methods: In total, 41 patients on insulin therapy were included. Patients were monitored for 72 h using RTCGMS. Arterial blood glucose (ABG) samples were obtained following the protocol established in the ICU. The results were evaluated using paired values (excluding those used for calibration) with the performance assessed using numerical accuracy. Nonparametric tests were used to determine statistically signi¿cant differences in accuracy. Results: In total, 956 ABG/RTCGMS pairs were analyzed. The overall median relative absolute difference (RAD) was 13.5%, and the International Organization for Standardization (ISO) criteria were 68.1%. The median RADs reported for patients with septic shock, with sepsis, and without sepsis were 11.2%, 14.3%, and 16.3%, respectively (P<0.05). Measurements meeting the ISO criteria were 74.5%, 65.6%, and 63.7% for patients with septic shock, with sepsis, and without sepsis, respectively (P<0.05). Conclusions: The results showed that the septic status of patients in¿uenced the accuracy of the RTCGMS in the ICU. Accuracy was signi¿cantly better in patients with septic shock in comparison with the other patient cohorts., This work was supported by the Spanish Ministry of Science and Innovation through grants DPI2007-66728-C02 and DPI-2010-20764-C02, the European Union through FEDER funds, and the Autonomous Government of Catalonia through 2009 SGR 523. Y.L. is grateful for the BR Grants of the University of Girona. The authors thank the Ph.D. candidate student Xavier Berjaga, who helped with the statistical analysis in this work. The authors thank the nursing staff of the ICU of Doctor Josep Trueta Hospital for their work; without them, this study could not have been conducted. Medtronic, Inc. provided some of the devices used in this study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

El Páncreas Artificial: Control Automático de Infusión de Insulina en Diabetes Mellitus Tipo 1, Artificial pancreas: automatic control of insulin infusion in type 1 diabetes mellitus

  • Bondía Company, Jorge|||0000-0001-7286-3719
  • Vehí, J.
  • Palerm, C. C.
  • Herrero, P.
[ES] La diabetes mellitus tipo 1 es una enfermedad crónica que afecta aproximadamente a 30 millones de personas en el mundo y se caracteriza por niveles de concentración de glucosa en sangre elevados producidos por una deficiencia absoluta de insulina. Ello produce numerosas complicaciones a largo plazo como retinopatía, nefropatía y neuropatía entre otras. Las terapias actuales basadas en el suministro de insulina exógena (por inyecciones o bomba de insulina), no consiguen normalizar los niveles de glucosa de forma eficiente. Los avances tecnológicos en la última década en sistemas de medición continua de glucosa e infusión de insulina, han impulsado el desarrollo del páncreas artificial, o control automático de infusión de insulina. En este trabajo se presentará, a modo de tutorial, el pasado, presente y futuro de esta tecnología, tan esperada por el paciente diabético. Se revisará el estado actual de la tecnología para la sensorización y actuación, principales desafíos desde el punto de vista de control, las diferentes ``escuelas'' y estudios clínicos del desempeño de controladores, así como herramientas de validación de controladores mediante simulación. Dada la complejidad del problema, el desarrollo del páncreas artificial será de forma escalonada, redundando progresivamente en la mejora de la calidad de vida del paciente. Los grandes avances en los últimos cinco años hacen preveer un horizonte cercano para la primera generación de páncreas artificial., [EN] Type 1 diabetes mellitus is a chronic disease that affects approximately to 30 million people worldwide and is characterized by high blood glucose concentration levels produced by an absolute deficiency of insulin. That produces numerous long-term complications like retinopathy, nephropathy and neuropathy among others. Current therapies based on the exogenous delivery of insulin (through injections or an insulin pump), do not manage to normalize the glucose levels efficiently. Technological advances in the last decade in continuous glucose monitoring and insulin infusion have been a springboard for the development of the artificial pancreas, or automatic control of insulin infusion. In this work, the past, present and future of this technology, so long awaited by the diabetic patient, will be presented in the form of a tutorial. Current technology for sensorization and actuation will be reviewed, as well as main challenges from the control point of view, different “schools of thought” and clinical studies for controllers performance evaluation, and tools for the validation of controllers through simulation. Due to the complexity of the problem, the development of the artificial pancreas will be staggered, resulting progressively in an improvement of the patient’s quality of life. The big advances during last five years foresee a close horizon for a first generation of artificial pancreas., Este trabajo ha sido realizado parcialmente gracias al apoyo del Ministerio de Ciencia e Innovación español, a través del proyecto DPI2007-66728-C02, de la Unión Europea a través de fondos FEDER y de la Wellcome Trust.